Wegovy works on the GLP-1 hormone, which suppresses appetite and signals the pancreas to produce insulin to break down sugars ...

Using the Saxenda pen correctly is essential for safe and effective weight loss management. While the pen is designed to be user-friendly, many people make mistakes that can reduce its effectiveness ...

Amidst this rapidly evolving landscape, white label AI tools have become pivotal for companies seeking to harness the power of AI without the extensive resources typically required for developing such ...

The Metropolitan Police is investigating an allegation of ‘malicious communication’ relating to a series of ‘poison pen’ letters regarding the BMA’s GP Committee chair. Last week, LMC leaders across ...

Here’s how it works. The Surface Pen and Surface Slim Pen 2 are the best options for modern Surface PCs; I've been using the former for years without issue, and the latter adds wireless charging ...

The FDA has ruled that Novo can include data from the Devote study on Tresiba’s (insulin degludec) label, which shows that it can reduce risk of hypoglycaemia by 40% compared with Sanofi’s ...

The companion app for the InPen digital insulin pen is designed to connect with the company’s latest Simplera continuous glucose monitor, offering users personalized dosing suggestions based on ...

Today's label printers range from small desktop units for file-folder paper labels to industrial-grade ones for labeling cables with plastic strips. Here's how to pick the right labeler ...

They are calling for the Danish multinational to withdraw its decision to discontinue its provision of human insulin pens “in South Africa and other developing countries”. MSF also wants the ...

Trouble is, Novo’s best-selling weight-loss treatment Wegovy, which has faced shortages, is the same as Ozempic, but at a different dose, and some doctors have prescribed the diabetes-fighting drug ...

Novo Nordisk is phasing out human insulin pens to focus on its newer diabetes and obesity medicines, sparking protests and concerns over access in low-income countries. Modern insulin, preferred in ...

Novo Nordisk, in a strategic shift, is set to phase out the production of human insulin pens globally, although it remains unclear when this will occur. The pharmaceutical giant is redirecting its ...